⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30321 | 0.79 | — | — | |
| SCHEMBL87709 | 0.79 | LPAR2 (0.31) | — | |
| SCHEMBL10932944 | 0.79 | — | — | |
| SCHEMBL15847030 | 0.79 | LPAR3 (0.50) | — | |
| SCHEMBL174096 | 0.79 | BTN3A1 (0.40) | — | |
| SCHEMBL11598005 | 0.77 | — | — | |
| SCHEMBL4562105 | 0.77 | — | — | |
| SCHEMBL11677557 | 0.77 | BTN3A1 (0.39) | — | |
| SCHEMBL3364236 | 0.77 | — | — | |
| Water SCHEMBL2238973 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399208-A1 | IRAK INHIBITOR FOR TREATING CYTOKINE RELEASE-RELATED CONDITIONS ASSOCIATED WITH INFECTION BY A RESPIRATORY VIRUS | Rigel Pharmaceuticals, Inc. (US) | 2024-07-17 | — | — | EP | claimed |
| CN-114686574-B | Method and kit for detecting nucleotide large fragment deletion | 厦门大学 | 2024-07-02 | — | — | CN | claimed |
| US-11788118-B2 | Method for detecting target nucleic acid sequences | XIAMEN ZEESAN BIOTECH CO., LTD. (CN) | 2023-10-17 | — | — | US | claimed |
| CN-111100862-B | Method for detecting bacterial serotypes | 厦门大学 | 2023-09-29 | — | — | CN | claimed |
| US-20230303555-A1 | PYRIMID-2-YL-PYRAZOLE COMPOUNDS AS IRAK INHIBITORS | RIGEL PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | US | claimed |
| WO-2023183377-A1 | PYRIMID-2-YL-PYRAZOLE COMPOUNDS AS IRAK INHIBITORS | RIGEL PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | WO | claimed |
| WO-2023038815-A1 | IRAK INHIBITOR FOR TREATING CYTOKINE RELEASE-RELATED CONDITIONS ASSOCIATED WITH INFECTION BY A RESPIRATORY VIRUS | RIGEL PHARMACEUTICALS, INC. (US) | 2023-03-16 | — | — | WO | claimed |
| EP-3640340-B1 | METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCES | XIAMEN ZEESAN BIOTECH CO LTD (CN) | 2022-06-29 | — | — | EP | claimed |
| EP-4003990-A1 | PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING THE COMPOUNDS AND/OR FORMULATIONS | Rigel Pharmaceuticals, Inc. (US) | 2022-06-01 | — | — | EP | claimed |
| CN-114364674-A | Pyrazole compounds, formulations thereof, and methods of using the compounds and/or formulations | 里格尔药品股份有限公司 | 2022-04-15 | — | — | CN | claimed |
| US-11111522-B2 | Method for detecting target nucleic acid sequences | XIAMEN UNIVERSITY (CN) | 2021-09-07 | — | — | US | claimed |
| WO-2021128823-A1 | METHOD FOR ASYMMETRIC AMPLIFICATION OF MULIPLE TARGET NUCLEIC ACIDS | 厦门大学 | 2021-07-01 | — | — | WO | claimed |
| WO-2021128860-A1 | METHOD FOR ASYMMETRIC AMPLIFICATION OF TARGET NUCLEIC ACID | 厦门大学 | 2021-07-01 | — | — | WO | claimed |
| WO-2021041898-A1 | PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING THE COMPOUNDS AND/OR FORMULATIONS | RIGEL PHARMACEUTICALS, INC. (US) | 2021-03-04 | — | — | WO | claimed |
| US-20210061798-A1 | PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING THE COMPOUNDS AND/OR FORMULATIONS | RIGEL PHARMACEUTICALS, INC. (US) | 2021-03-04 | — | — | US | claimed |
| US-20200140931-A1 | METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCES | XIAMEN ZEESAN BIOTECH CO., LTD. (CN) | 2020-05-07 | — | — | US | claimed |
| EP-3640340-A1 | METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCES | Xiamen University (CN) | 2020-04-22 | — | — | EP | claimed |
| EP-2344447-A2 | GABA CONJUGATES AND METHODS OF USE THEREOF | Kyphia Pharmaceuticals, Inc. (US) | 2011-07-20 | — | — | EP | claimed |
| WO-2010042759-A2 | GABA CONJUGATES AND METHODS OF USE THEREOF | KYPHIA PHARMACEUTICALS INC (US) | 2010-04-15 | — | — | WO | claimed |
| US-20080098643-A1 | Ethanol modifier and its application | HOU JINPENG | 2008-05-01 | — | — | US | claimed |